Vima Doses First Patient in Parkinson's Tremor Trial
Vima Therapeutics begins its Phase 2 Vista PD study of VIM0423 for tremor that current Parkinson's treatments do not adequately control.
Cambridge Diseases News
Alzheimer’s
MIT Researchers Discovered Adaptive Brain Circuits
A study published August 17, 2026, revealed how mouse brain neurons dynamically switch roles to manage memory and planning.
Autism
Live Poll
Do you trust that pharmaceutical companies are sufficiently prioritizing the development of treatments for rare diseases?
Skylark Bio Added Gene Therapy for Angelman Syndrome
The Cambridge-based company has expanded its development pipeline to include a new candidate for the rare genetic disorder.
COVID-19
Live Poll
Do you believe academic fellowships effectively foster leadership among health professionals in developing nations?
Harvard Opens Applications for Global Health Fellowship
The Harvard Global Health Institute is now accepting applications for the upcoming year-long leadership fellowship program.
Stroke
MIT Develops Implant to Spread Brain Drugs
The experimental LUCID device uses ultrasound to help medicines move further through brain tissue, tested so far in gel and mice.
Allergies
Live Poll
Do you believe private philanthropic initiatives effectively accelerate the development of new medical treatments?
Food Allergy Science Initiative Launched New Accelerator
The Cambridge-based group has unveiled a $10 million fund to fast-track potential food allergy treatments.
